Kelly Olsen defended her doctoral dissertation, Shared Minor Histocompatibility Antigen Discovery and Targeting in the Context of Allogeneic Hematopoietic Cell Transplant for Hematologic Malignancies. The presentation took place on Friday, February 24, 2023.
Her research, which was conducted under the guidance of Dr. Benjamin Vincent, focused on the discovery of shared, leukemia-specific minor histocompatibility antigens for therapeutic applications in acute myeloid leukemia. In addition, Kelly was awarded the M&I Scientific Achievement Award. Kelly will return to medical school this summer to complete her clinical rotations.
Congratulations, Dr. Olsen, and thank you for your contributions to M&I scientific advancement!